Antivenom Dosing Algorithm
ورودیهای بالینی بیمار
حداقل ۱ — حداکثر ۳۰۰ • واحد: kg
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- No Treatment0–0
- Standard Initial Dose4–6
- Higher Initial Dose6–12
Clinical Decision Pathway
Clinical Decision Pathway & Next Steps
Toxicology & Overdose — سمشناسی، اوردوز و مسمومیتها
Clinical Rationale:
In acetaminophen toxicity calculate NAC dosing and predict liver failure with King’s College criteria; estimate toxic alcohol levels, guide antivenom dosing, and quantify opioid overdose risk with MME.
Estimated Ethanol (and Toxic Alcohol) Serum Concentration Based on Ingestion
تخمین غلظت سرمی اتانول و الکلهای سمی
Recommended Clinical Next Steps:
Morphine Milligram Equivalents (MME) Calculator
محاسبهگر معادل میلیگرم مورفین (MME)
Why next: Daily opioid burden and overdose risk threshold
The Antivenom Dosing Algorithm calculates assessing acute poisoning severity, antidote indications, and fatal toxicity trajectory. Key inputs include signs of envenomation. Scores guide administering specific antidote therapy, gastrointestinal decontamination, and continuous telemetry monitoring. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Doses antivenom (CroFab only, not Anavip) for pit viper snakebites. This unified treatment algorithm assists with quick identification and management of patients who may benefit from treatment with Crotalidae Polyvalent Immune Fab (CroFab®).
Clinical Indication
The Antivenom Dosing Algorithm is indicated for bedside clinical practice to support Doses antivenom (CroFab only, not Anavip) for pit viper snakebites. This unified treatment algorithm assists with quick identification and management of patients who may benefit from treatment with Crotalidae Polyvalent Immune Fab (CroFab®).. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with acute pharmaceutical overdose, agricultural pesticide ingestion, toxic gas inhalation, or venomous envenomation. Clinical application is indicated across Poison control centers, acute toxicology wards, emergency resuscitation rooms, and intensive care.
Limitations & Contraindications
Initial serum concentrations for sustained-release or co-ingested anticholinergic agents may falsely appear low before delayed absorption peaks. Clinical exclusion: For CroFab administration only - do not use for Anavip dosing.
Clinical Pearls & Action Plan
Rapid clinical toxidrome identification guides immediate antidote administration; do not wait for confirmatory toxicology assays.
Algorithm-based dosing: Initial dose 4-6 vials (up to 12 for severe cases), additional 4-6 vials if control not achieved, maintenance 2 vials q6h x 3 doses
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| signs_of_envenomation | string | Yes | Presence of signs of envenomation including swelling, tenderness, redness, ecchymosis, or blebs at bite site; elevated protime, decreased fibrinogen or platelets; systemic signs (hypotension, bleeding beyond puncture site, refractory vomiting, diarrhea, angioedema, neurotoxicity) |
| severity_grade | string | Yes | Clinical severity grade of envenomation based on local, systemic, and hematologic effects |
| patient_weight_kg | float | Yes | Patient weight in kilograms (dosing is same for adults and pediatrics)(kg) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–0 | No Treatment | No antivenom needed |
| 4–6 | Standard Initial Dose | Standard initial antivenom dose |
| 6–12 | Higher Initial Dose | Higher initial antivenom dose for severe cases |
Evidence-Based References (EBM)
- Lavonas EJ, Ruha AM, Banner W, et al. Unified treatment algorithm for the management of crotaline snakebite in the United States: results of an evidence-informed consensus workshop. BMC Emerg Med. 2011;11:2. doi: 10.1186/1471-227X-11-2DOI: 10.1186/1471-227X-11-2
- Dart RC, Seifert SA, Boyer LV, et al. A randomized multicenter trial of crotalinae polyvalent immune Fab (ovine) antivenom for the treatment for crotaline snakebite in the United States. Arch Intern Med. 2001;161(16):2030-2036.
- CroFab® Prescribing Information. BTG International Inc.; August 2018.